The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc worldwide due to inadequate risk assessment regar...

This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. Information and data on COVID-19 are rapidly evolving. This guidance includes general information to consider. Clinicians s...

In a preliminary clinical study we observed that the combination of hydroxychloroquine and azithromycin was effective active against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount importance to define when a treated patient ...

Includes: Interferons, Nucleoside analogs, Protease inhibitors, Furin Convertase Cleavage inhibitors, Reverse transcriptase inhibitors, RNA Polymerase/Synthesis Inhibitors, Neuraminidase inhibitors, Angiotensin II receptor blockers, Endosome fusion inhibitors/ Endosome ...

As the medical community frantically scrambles to address SARS-CoV2, we in the natural community can also be investigating the tools we have that may be helpful during this pandemic. As a scientist who is not a clinician, my opinions come from research, not clinical exp...

Purpose: Emphysema and chronic obstructive lung disease were previously identified as major risk factors for severe disease progression in COVID-19. Computed tomography (CT)-based lung-density analysis offers a fast, reliable, and quantitative assessment of lung density...

This work highlights the prospect of computer-aided, structurebased traditional Chinese medicine drug discovery for the novel coronavirus pneumonia. These approaches helped to narrow down the large libraries of compounds into a subset in a relatively short time with lim...

[Presentación] Este documento técnico presenta las Normativas de Planificación del Ministerio de Salud Pública y Bienestar Social para dar respuesta al Novel Coronavirus (SARS-CoV-2) con una estrategia multisectorial capaz de mitigar el impacto que podría ocasionar a la...

A growing body of literature on the 2019 novel coronavirus (SARS-CoV-2) is becoming available, but a synthesis of available data has not been conducted. We performed a scoping review of currently available clinical, epidemiological, laboratory, and chest imaging data re...

The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable sa...